EPCs disturb metabolic homeostasis through mechanisms such as aryl hydrocarbon receptor (AhR) activation and mitochondrial dysfunction, both of which have been implicated in insulin resistance, T2D, and metabolic syndrome in numerous studies [5]. The gene discussed is AHR; the disease is metabolic syndrome.